| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/15/2007 | CN101015521A Anticancer composition loading both antimetabolite medicament and synergistic agent |
| 08/15/2007 | CN101015520A Alendronate pharmaceutical composition and its prepn. technique |
| 08/14/2007 | US7256258 Preparing stereospecific growth hormone releasing factor (GRF) for diagnosis and treatment of growth hormone deficiencies |
| 08/14/2007 | US7256234 Providing a polymer matrix base which comprises one or more hydrophobic polymers, combining with a hybrid system comprisingdimethyl sulfoxide and poly(1-vinyl-2-pyrrolidones to provide a matrix base/hybrid system mixture; combining with pharmaceutically active substances |
| 08/14/2007 | US7256216 Powder mixture of aminobutyric acid and solid polyol; therapy for brain disorders; central nervous system disorders; analgesics; headaches |
| 08/14/2007 | US7256043 Transfection complexes |
| 08/14/2007 | US7256026 Activated yeast cell culture for improving immune functions of animals; health foods, drinks and supplement; immunosuppression; immunotherapy |
| 08/14/2007 | US7255881 For therapy of undesirable skin conditions |
| 08/14/2007 | US7255880 Treatment of endothelin-related disorders |
| 08/14/2007 | US7255876 Composition comprises sustained-release fine particles and manufacturing method thereof |
| 08/14/2007 | US7255875 Integrin targeted imaging agents |
| 08/14/2007 | US7255870 Composition containing a semicrystalline polymer, uses thereof, and method for making |
| 08/14/2007 | US7255868 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies |
| 08/14/2007 | CA2354047C Method for the treatment of inflammation |
| 08/14/2007 | CA2223259C Pharmaceutical formulations of highly lipophilic camptothecin derivatives |
| 08/14/2007 | CA2173504C Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof |
| 08/10/2007 | CA2572764A1 Local system for the release of active principle and process for its manufacture |
| 08/09/2007 | WO2007089931A1 Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| 08/09/2007 | WO2007089490A1 Sterilized nanoparticulate glucocorticosteroid formulations |
| 08/09/2007 | WO2007089043A1 Liposome preparation |
| 08/09/2007 | WO2007088952A1 Liposome preparation comprising substance having anti-tumor activity |
| 08/09/2007 | WO2007088783A1 Eye drop/wearing fluid for soft contact lenses |
| 08/09/2007 | WO2007088327A1 Composition for promoting vascular smooth muscle relaxation |
| 08/09/2007 | WO2007088035A1 A pharmaceutical composition comprising perindopril |
| 08/09/2007 | WO2007087806A1 A topical composition comprising an antibacterial substance |
| 08/09/2007 | WO2007087700A1 Process for the preparation of formulations of angiotensin converting enzyme inhibitors and product |
| 08/09/2007 | WO2007060512A3 Compositions containing topical active agents and pentylene glycol |
| 08/09/2007 | WO2007059404A3 Duocarmycin derivatives as novel cytotoxic compounds and conjugates |
| 08/09/2007 | WO2007054976A3 Lipid based controlled release pharmaceutical composition |
| 08/09/2007 | WO2007039533A3 Antifungal composition |
| 08/09/2007 | WO2007024719A3 Long acting injectable parasiticidal formulations |
| 08/09/2007 | WO2007022924A3 Pharmaceutical compositions with melting point depressant agents and method of making same |
| 08/09/2007 | WO2007016150A3 Mutated pseudomonas exotoxins with reduced antigenicity |
| 08/09/2007 | WO2007002222A3 Psma antibody-drug conjugates |
| 08/09/2007 | WO2006128639A3 Process for the preparation and isolation of phosphatides |
| 08/09/2007 | WO2006114105A8 Use of modified factor vii for treating bleeding |
| 08/09/2007 | US20070185314 Crystals of LuxP and complexes thereof |
| 08/09/2007 | US20070185311 Peptide-Based Multimeric Targeted Contrast Agents |
| 08/09/2007 | US20070185218 Controlled release formulation for oral administration of metformin |
| 08/09/2007 | US20070185201 Compositions and Methods for Preventing or Treating Inflammatory Bowel Disease |
| 08/09/2007 | US20070185040 Guanidinium derivatives for improved cellular transport |
| 08/09/2007 | US20070185008 Stereocomplex hydrogels with tunable degradation times |
| 08/09/2007 | US20070184267 Phototpolymerized macromolecules self-assembled around carbon nanotubes, a method of producing them, and their applications |
| 08/09/2007 | US20070184114 Formulation for topical non-invasive application in vivo |
| 08/09/2007 | US20070184112 Volume Efficient Controlled Release Dosage Form |
| 08/09/2007 | US20070184105 Comsposition for stablizing epigallocatechin gallate (egcg) in water phase and preparation method thereof |
| 08/09/2007 | US20070184103 Process for producing fenofibrate tablets |
| 08/09/2007 | US20070184092 Methods and compositions for modulating tocol content |
| 08/09/2007 | US20070184091 Animal feed composition |
| 08/09/2007 | US20070184090 PUFA supplements |
| 08/09/2007 | US20070184089 Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use |
| 08/09/2007 | US20070184070 Recombinant toxin fragments |
| 08/09/2007 | US20070184055 Treatment with anti-erbb2 antibodies |
| 08/09/2007 | US20070184050 Stable water-based medicinal preparation containing antibody |
| 08/09/2007 | US20070184048 Re-targeted toxin conjugates |
| 08/09/2007 | US20070184019 Pharmaceutical composition comprising an active principal and sulphobetaine |
| 08/09/2007 | US20070183980 Thermoforming by extrusion without discoloration; controlled release |
| 08/09/2007 | US20070183974 Method and apparatus for production of a skin graft and the graft produced thereby |
| 08/09/2007 | DE10066158B4 Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms Use of a transdermal therapeutic system for the treatment of Restless Legs Syndrome |
| 08/09/2007 | CA2641819A1 Composition for promoting vascular smooth muscle relaxation |
| 08/09/2007 | CA2641146A1 Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| 08/09/2007 | CA2640598A1 Liposome preparation |
| 08/09/2007 | CA2640444A1 Sterilized nanoparticulate glucocorticosteroid formulations |
| 08/09/2007 | CA2637846A1 A topical composition comprising an antibacterial substance |
| 08/09/2007 | CA2637316A1 A pharmaceutical composition comprising perindopril |
| 08/09/2007 | CA2635718A1 Methods of using hedgehog kinase antagonists to inhibit hedgehog signaling and to treat hedgehog mediated disorders |
| 08/09/2007 | CA2634879A1 Pharmaceutical formulations of oxcarbazepine and methods for its preparation |
| 08/09/2007 | CA2577468A1 Composition and method for pre-surgical skin disinfection |
| 08/08/2007 | EP1816475A1 Use of cyanine dyes for the diagnosis of disease associated with angiogenesis |
| 08/08/2007 | EP1816138A1 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 08/08/2007 | EP1815869A1 Method of changing morphology of block copolymer |
| 08/08/2007 | EP1815868A2 Drug absorptivity improving agent |
| 08/08/2007 | EP1815857A1 A pharmaceutical composition comprising perindopril |
| 08/08/2007 | EP1815855A1 Pharmaceutical composition for modified release insulin sensitiser |
| 08/08/2007 | EP1815852A1 Nonaqueous preparation for percutaneous absorption containing nonsteroidal antiflammatory analgesic |
| 08/08/2007 | EP1815848A1 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 08/08/2007 | EP1815847A2 Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 08/08/2007 | EP1815846A2 Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| 08/08/2007 | EP1815845A2 Biocompatible compounds for pharmaceutical drug delivery systems |
| 08/08/2007 | EP1814924A2 Amphiphilic star block copolymers |
| 08/08/2007 | EP1814915A1 Neutralising antibody molecules having specificity for human il-17 |
| 08/08/2007 | EP1814905A1 Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest |
| 08/08/2007 | EP1814843A1 Stable crystalline modifications of dotap chloride |
| 08/08/2007 | EP1814593A1 An oral preparation having improved bioavailability |
| 08/08/2007 | EP1814592A2 Antiviral composition |
| 08/08/2007 | EP1814591A1 Bioactive compositions |
| 08/08/2007 | EP1814581A2 Stable formulations of peptides |
| 08/08/2007 | EP1814558A2 Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis |
| 08/08/2007 | EP1814524A1 Solid, oral, microparticulate dosage form which has been designed to prevent misuse |
| 08/08/2007 | EP1814523A1 Solid, oral drug form which has been designed to prevent misuse |
| 08/08/2007 | EP1814522A1 Method of formation of the shape-retentive aggregates of gel particles and their uses |
| 08/08/2007 | EP1814518A1 Triple natural polymer viscoelastic composition |
| 08/08/2007 | EP1814517A1 Nonaqueous liquid parenteral aceclofenac formulation |
| 08/08/2007 | EP1814516A1 Use of a liquid allergy vaccine formulation for oromucosal administration |
| 08/08/2007 | EP1753462B1 Process for the preparation of doxorubicin conjugates with lactosaminated human albumin and the obtained conjugates |
| 08/08/2007 | EP1723172B1 Erythropoietin liquid formulation |
| 08/08/2007 | EP1701709A4 Confection product containing urea |
| 08/08/2007 | EP1664044B1 S-tenatoprazole sodium monohydrate salt and the use thereof in the form of a proton pump inhibitor |
| 08/08/2007 | EP1536767B1 Osmotic delivery system with early zero order push power engine comprising an osmotic agent dispersed in the fluid vehicle |
| 08/08/2007 | EP1487832B1 Micronized crystalline tiotropium bromide |